You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 12, December 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Abstract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Amyotrophic Lateral Sclerosis
 •Neuromuscular diseases
 •Alert me on articles by topic

Accumulation of Neurofilaments and SOD1-Immunoreactive Products in a Patient With Familial Amyotrophic Lateral Sclerosis With I113T SOD1 Mutation

Yasumasa Kokubo, MD; Shigeki Kuzuhara, MD; Yugo Narita, MD; Koki Kikugawa, MD; Ryoichi Nakano, MD; Takashi Inuzuka, MD; Shoji Tsuji, MD; Masatoshi Watanabe, MD; Tomonori Miyazaki, MD; Shigeo Murayama, MD; Yasuo Ihara, MD

Arch Neurol. 1999;56:1506-1508.

ABSTRACT

Objective  To report neuropathologic features of argyrophilic inclusions in the anterior horn cells, motor cortex Betz cells, and neurons of the medullary reticular formation, spinal posterior horn, and Clarke column in a Japanese case of familial amyotrophic lateral sclerosis with I113T substitution in exon 4 of the copper-zinc superoxide dismutase (SOD1) gene.

Methods and Results  These inclusions were stained pale pink on the hematoxylin-eosin stain and dark on the Bielschowsky stain. They were positive for antibodies to phosphorylated neurofilaments, ubiquitin, and SOD1. On electron microscopy, they consisted of abundant intermediate filaments of 10 to 20 nm in diameter with disordered array indicating neurofilaments.

Conclusion  These findings suggest that the I113T mutation induces accumulation of neurofilaments and SOD1 in the central nervous system neurons.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Author information
 •References

AMYOTROPHIC lateral sclerosis (ALS) is a fatal disease characterized by progressive degeneration of the upper and lower motor neurons. Approximately 10% of cases are inherited as an autosomal dominant trait, and 15% to 20% of cases of familial ALS (FALS) have mutations of copper-zinc superoxide dismutase (SOD1) gene on chromosome 21.1 We report neuropathologic findings of a Japanese case of FALS with the I113T mutation of the SOD1 gene. The gene analysis of this case was previously reported by Kikugawa et al.2


PATIENTS AND METHODS
 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Author information
 •References

The propositus and his wife, who were first cousins, were both affected by ALS. The propositus developed muscle weakness and atrophy in the right hand in February 1994, when he was 68 years old. Neurologic examination in September 1994 showed marked atrophy with fasciculation and weakness in the upper and lower extremities, but no bulbar or pyramidal signs. He died of respiratory failure at age 69 years in July 1995, about 17 months after the onset of the disease.

The wife of the propositus developed muscle weakness of the right hand in June 1976, when she was 48 years old, and was diagnosed as having ALS. She was found in a deep coma and in cardiac arrest caused by respiratory failure on August 31, 1984, and required mechanical respiratory assistance for 10 months, until her death at age 57 years in June 1985.

Sections of the brains and spinal cords, fixed with formalin and embedded in paraffin, of the propositus and his wife were prepared for hematoxylin-eosin, Klüver-Barrera, Bodian, modified Bielschowsky, and Gallyas staining. The immunohistochemical investigations were done with the avidin-biotin-peroxidase complex technique by means of the following primary antibodies: anti–phosphorylated neurofilament monoclonal antibody (Sternberger Monoclonals Inc, Baltimore, Md; dilution, 1:500), anti–SOD1 polyclonal antibody (raised by Kohtaro Asayama, MD, Department of Pediatrics, Yamanashi Medical College, Yamanashi, Japan3; 1:5000), anti–ubiquitin polyclonal antibody (Sigma-Aldrich Corp, St Louis, Mo; 1:100), anti-{tau} antibody (raised by Yasuo Ihara, MD, Department of Neuropathology, University of Tokyo, Tokyo, Japan4; 1:2000); and anti-amyloid {beta} protein antibody (raised by Dr Yasuo Ihara4; 1:1000). The anterior horn of the lumbar cord and the cerebral motor cortex of the propositus were examined by electron microscopy.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Author information
 •References

Mutation analysis of the SOD1 gene of the propositus disclosed I113T substitution in exon 4 as a heterozygous site.2 We failed to extract DNA of the wife from the paraffin-embedded tissues because of severe ischemic changes.

The brain of the propositus weighed 1305 g. Histological examination showed marked loss of the anterior horn cells with large axonal spheroids, more severely in the cervical cord than in the lumbar cord. There were many swollen anterior horn cells and a moderate number of Betz cells with heavily argyrophilic inclusions of redundant ribbonlike structures in the perikaryon. Similar inclusions were occasionally found in the reticular formation of the medulla oblongata and in the posterior horn and Clarke column of the spinal cord. The results of immunohistochemical examination of the argyrophilic inclusions of both the spinal motor neurons and the Betz cells are shown in Figure 1. There was a moderate to strong reaction with Bielschowsky stain, equivocal with Bodian stain, negative with Gallyas stain, strong with anti–phosphorylated neurofilament monoclonal antibody, moderate with anti-SOD1 polyclonal antibody, weak with anti–ubiquitin polyclonal antibody, and negative with anti-{tau} antibody and anti-amyloid {beta} protein antibody. On electron microscopy, the cytoplasmic inclusions in the anterior horn cells and the Betz cells consisted of accumulation of abundant intermediate filaments of disordered array and a variety of diameters between 10 and 20 nm, suggesting neurofilaments (NFs) (Figure 2). There were no neurofibrillary tangles, Bunina bodies, Lewy body–like inclusions, hyalin inclusions, skeinlike inclusions, or senile plaques.



View larger version (48K):
[in this window]
[in a new window]
Figure 1. Immunohistochemical features of the cytoplasmic inclusions in Betz cells in the motor cortex (left, anti–phosphorylated neurofilament monoclonal antibody, original magnification x132; right, SOD1, original magnification x160). The inclusions of lumbar anterior horn cells showed similar staining.




View larger version (116K):
[in this window]
[in a new window]
Figure 2. Electron micrograph of the inclusion of the anterior horn cell showing filaments of 10 to 20 nm in diameter with a disordered array suggesting neurofilaments.


The brain of the propositus' wife weighed 990 g, and neurons of the brain and spinal cord were nearly gone because of the severe anoxic and ischemic incident. Argyrophilic nerve cells in the spinal cord, pons, and the pontine and medullary reticular formation rarely existed, and they were weakly stained with anti–phosphorylated neurofilament monoclonal antibody and anti-SOD1.


COMMENT
 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Author information
 •References

The propositus is, to our knowledge, the first Japanese patient with FALS with I113T SOD1 gene mutation to undergo autopsy, in which argyrophilic cytoplasmic inclusions were verified neuropathologically not only in the anterior horn cells and the motor cortex Betz cells but also in the neurons of the medullary reticular formations, spinal posterior horns, and Clarke column. The argyrophilic inclusions reacted intensely with antibody to the phosphorylated epitope of NFs and consisted of abundant intermediate filaments of 10 to 20 nm in diameter with a disordered array suggesting NFs on electron microscopy. In addition, these inclusions were stained with anti-SOD1 antibody.

Four autopsy cases of FALS with I113T mutation were reported previously, 1 from Canada and 3 from the United Kingdom. The most characteristic feature common to them was accumulation of filamentous materials in nerve cells, either NFs5-6 or neurofibrillary tangles.7 Rouleau et al5 from Canada reported a case that coexisted with massive accumulations of NFs in the anterior horn cells. Ince et al6 from the United Kingdom recently reported 2 cases in which there were hyaline conglomerate inclusions in the motor and nonmotor neurons. These inclusions reacted strongly with antibodies to phosphorylated and nonphosphorylated epitopes of NFs, but not with anti-SOD1 antibody. Orrell et al7 from the United Kingdom described 1 patient who had survived for more than 20 years and showed neurofibrillary tangles in the neurons of the globus pallidus, substantia nigra, locus ceruleus, and inferior olivary nuclei.

The coexistent immunoreactivity with NFs and SOD1 may be unique to the present case or it may result from the different properties of the antibodies used. The existence of FALS that has the same I113T SOD1 mutation with similar neuropathologic findings among different ethnic groups and races suggests that the I113T mutation is firmly related to massive accumulation of NFs in the central nervous system that leads to degeneration of nerve cells.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Author information
 •References

Accepted for publication February 19, 1999.

This study was supported in part by a Grant-in-Aid of the Research Committee of CNS Degenerative Diseases, the Ministry of Health and Welfare, and by a Grant-in-Aid for the Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture, Tokyo, Japan.

We thank Hidehiro Mizusawa, MD, Department of Neurology, Tokyo Medical and Dental University, Tokyo, Japan, for invaluable comments on the immunohistochemical staining with the SOD1 and anti–phosphorylated neurofilament monoclonal antibodies; Kohtaro Asayama, MD, Department of Pediatrics, Yamanashi Medical College, Yamanashi, Japan, for the generous gift of anti–copper-zinc SOD1 antibody; Nobuo Ito, MD, Department of Neurology, Mie University School of Medicine, Mie, Japan, for extracting DNA from the paraffin-embedded tissues; and Junko Saishoji and Hisami Akatsuka for technical assistance in preparing tissues for histopathology, immunohistochemistry, and electron microscopy studies.

Reprints: Shigeki Kuzuhara, MD, Department of Neurology, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan (e-mail: kuzuhara{at}clin.medic.mie-u.ac.jp).

From Departments of Neurology (Drs Kokubo, Kuzuhara, and Narita) and Pathology (Dr Watanabe), Mie University School of Medicine, Tsu, Mie, Japan; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan (Drs Kikugawa, Nakano, Inuzuka, and Tsuji); Department of Internal Medicine, Tsu Seikyo Hospital, Tsu, Mie (Dr Miyazaki); and Departments of Neurology (Dr Murayama) and Neuropathology (Dr Ihara), Institute of Brain Research, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Patients and methods
 •Results
 •Comment
 •Author information
 •References

1. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62. FULL TEXT | PUBMED
2. Kikugawa K, Nakano R, Inuzuka T, et al. A missense mutation in the SOD 1 gene in patients with amyotrophic lateral sclerosis from the Kii Peninsula and its vicinity, Japan. Neurogenetics. 1997;1:113-115. FULL TEXT | ISI | PUBMED
3. Munim A, Asayama K, Dobashi K, Suzuki K, Kawaoi A, Kato K. Immunohistochemical localization of superoxide dismutases in fetal and neonatal rat tissues. J Histochem Cytochem. 1992;40:1705-1713. ABSTRACT
4. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated, a light and electron microscopic immunocytochemical study. Acta Neuropathol. 1988;75:345-353. FULL TEXT | PUBMED
5. Rouleau GA, Clark AW, Rooke K, et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol. 1996;39:128-131. FULL TEXT | ISI | PUBMED
6. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol. 1998;57:895-904. ISI | PUBMED
7. Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, de Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry. 1995;59:266-270. ABSTRACT

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(12):1538-1539.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The G93C Mutation in Superoxide Dismutase 1: Clinicopathologic Phenotype and Prognosis
Regal et al.
Arch Neurol 2006;63:262-267.
ABSTRACT | FULL TEXT  

Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis
Jonsson et al.
Brain 2004;127:73-88.
ABSTRACT | FULL TEXT  

Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans
MOGHADASIAN et al.
FASEB J. 2001;15:2623-2630.
ABSTRACT | FULL TEXT  

Familial Amyotrophic Lateral Sclerosis With a Novel Leu126Ser Mutation in the Copper/Zinc Superoxide Dismutase Gene Showing Mild Clinical Features and Lewy Body-Like Hyaline Inclusions
Takehisa et al.
Arch Neurol 2001;58:736-740.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.